top of page

CANNABINOID SCIENCE, BUILT FOR MEDICINE

Medical cannabis, held to pharma-grade standards.

IMCI formulations are built on NanoVATE Delivery™, our nano-emulsion platform, for higher bioavailability, faster onset and more consistent absorption than standard cannabis oil. We offer them to licensed partners in regulated medical cannabis markets.

THE DELIVERY ADVANTAGE

Higher exposure. Faster delivery.

High bioavailability and absorption rate indicator

Higher exposure

Than oil-based comparators, in IMCI’s preclinical and early human studies.

Rapid drug delivery onset timeline icon

Within minutes

THC detected in the blood with the sublingual format, in preclinical studies.

Human data on the underlying technology.

Peer-reviewed

Human data on the underlying technology.

WORK WITH IMCI

Who we work with.

Licensed distribution and pharmacy partnership model

Partners

Distributors, pharmacies and licensed operators. We offer three supply routes, matched to each market’s regulation.

Partners & Markets →
Academic and clinical research formulation collaboration

Researchers

Academic and clinical researchers working on cannabinoid compositions. We collaborate on formulation and pharmacokinetic studies.

Research collaboration →
Medical and clinical evidence for physicians and pharmacists

Healthcare professionals

Physicians and pharmacists. See the evidence behind the platform, and how our formulations are specified and tested.

See the evidence →
Investment in pharma-grade medical cannabinoid formulations

Investors

Medical cannabis is moving from flower to pharma-grade. See the opportunity and why now.

​

​

Investors →

NANOVATE DELIVERY™

Cannabinoids don’t mix with water. NanoVATE Delivery™ changes that.

Cannabinoids are fat-soluble, so standard cannabis oils are absorbed slowly and unevenly. NanoVATE Delivery™ forms nano-sized droplets on contact with water or body fluids, keeping cannabinoids dispersed and ready for absorption.

3X THC

higher peak blood levels in a published human study of the underlying technology

4X CBD

Higher peak blood levels in the same study, compared with an approved oromucosal cannabinoid spray.

5-10 min

THC detected in the blood in IMCI's preclinical studies of the sublingual format

Self-emulsifying NanoVATE droplet dispersion mechanism diagram

Self-Emulsifying

Droplets form spontaneously, with no special preparation.

Comparison of L-NanoVATE liquid and S-NanoVATE solid dosage formats

Liquid and Solid Format

L-NanoVATE for liquids, S-NanoVATE for tablets, capsules and edibles.

HOW WE SUPPLY

One platform. Three market-ready routes.

Each market regulates medical cannabis differently. We formulate NanoVATE Delivery™ products for the supply route each market requires.

Finished medical cannabis blister pack and tablet packaging

Final dosage form

Finished medical cannabis products, ready for dispensing, for supply under each market’s medical cannabis framework. 

Israel / United Kingdom / Australia

Magistral compounding formulation jars for pharmacies

Magistral

Formulations supplied to pharmacies that compound medical cannabis on prescription. 

Germany / Switzerland

Standardized cannabinoid PreMix ingredient containers for manufacturers

PreMix

A standardized cannabinoid ingredient for licensed manufacturers to use in their own products. 

United States

OUR BRANDS

Two brands, one platform.

iCann pharmaceutical cannabinoid product line

iCann

Our medical range, built on NanoVATE Delivery™ and supported by scientific research.

iCann products →
Ci consumer leisure cannabinoid line packaging options

Ci

Our leisure line, built on the same platform. We work flexibly with licensed partners, including private label under the partner’s own brand.

Ci products →

SCIENCE AND RECOGNITION

Research with a path to market.

GET IN TOUCH

Let’s talk.

Physician, pharmacist, distributor or investor, tell us what you need and the right person on our team will follow up.

IMCI Pharmaceuticals is a pharmaceutical company developing cannabinoid formulations. Statements describe platform characteristics and are not medical claims for any specific product. Product availability, labeling and marketing are subject to each market’s regulations.

bottom of page